Fingerprint
Dive into the research topics where Evalyn E.A.P. Mulder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Letter Re: Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trial
van Dijk, B., Janssen, J. C., Mulder, E. E. A. P., de Joode, K. & van der Veldt, A. A. M., 9 Sept 2025, In: European Journal of Cancer. 227, 115635.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile -
Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol
Janssen, J. C., van Dijk, B., de Joode, K., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Jalving, M., de Jonge, M. J. A., Joosse, A., Kapiteijn, E., Kamphuis-Huismans, A. M., Naipal, K. A. T., Piersma, D., Rikhof, B., Westgeest, H. M., Vreugdenhil, G. & Oomen-de Hoop, E. & 2 others, , 23 May 2024, In: BMC Cancer. 24, 1, 632.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Citations (Scopus)44 Downloads (Pure) -
Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A multicenter prospective Dutch study
Stassen, R. C., Mulder, E. E. A. P., Mooyaart, A. L., Francken, A. B., van der Hage, J., Aarts, M. J. B., van der Veldt, A. A. M., Verhoef, C. & Grünhagen, D. J., Dec 2023, In: European Journal of Surgical Oncology. 49, 12, 107249.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile17 Citations (Scopus)57 Downloads (Pure) -
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
Janssen, J. C., Mulder, E. E. A. P. & van der Veldt, A. A. M., 19 Jan 2023, In: The New England journal of medicine. 388, 3, p. 283-284Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
1 Citation (Web of Science) -
The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma
Derks, S. H. A. E., de Joode, K., Mulder, E. E. A. P., Ho, L. S., Joosse, A., de Jonge, M. J. A., Verhoef, C., Grünhagen, D. J., Smits, M., van den Bent, M. J. & van der Veldt, A. A. M., 1 Dec 2022, In: ESMO Open. 7, 6, p. 100600 5 p., 100600.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Citations (Scopus)120 Downloads (Pure)